Breast Cancer: Targets and Therapyhttps://www.dovepress.com/feed/journal/69New articles released by Dove Press for Breast Cancer: Targets and Therapyen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press Breast Cancer: Targets and TherapyBreast Cancer: Targets and Therapyhttps://www.dovepress.com/feed/journal/69https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancerhttps://www.dovepress.com/the-impact-of-androgen-receptor-expression-on-neoadjuvant-therapy-in-h-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyTue, 12 May 2026 19:00:00 +1200https://doi.org/10.2147/BCTT.S595222ADPB Sensitivity in Breast Cancer is Correlated with LAT1 Expression: An in vitro Study of a Novel Theranostic Candidatehttps://www.dovepress.com/adpb-sensitivity-in-breast-cancer-is-correlated-with-lat1-expression-a-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyThu, 07 May 2026 04:55:00 +1200https://doi.org/10.2147/BCTT.S564513Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Reviewhttps://www.dovepress.com/immune-checkpoint-blockade-and-emerging-combination-platforms-in-breas-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyTue, 05 May 2026 00:25:00 +1200https://doi.org/10.2147/BCTT.S588323Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Studyhttps://www.dovepress.com/efficacy-safety-and-prognostic-factors-of-dalpiciclib-combined-with-en-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyMon, 04 May 2026 16:20:00 +1200https://doi.org/10.2147/BCTT.S589939Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancerhttps://www.dovepress.com/hematologic-glyco-signatures-emerging-blood-based-sugar-codes-linked-t-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyFri, 01 May 2026 19:05:00 +1200https://doi.org/10.2147/BCTT.S603801Uncertainty-Aware Machine Learning for Predicting Axillary Lymph Node Metastasis Using Breast MRIhttps://www.dovepress.com/uncertainty-aware-machine-learning-for-predicting-axillary-lymph-node--peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyFri, 01 May 2026 03:10:00 +1200https://doi.org/10.2147/BCTT.S599211Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancerhttps://www.dovepress.com/genetic-correlation-of-mir-423-polymorphism-rs8067576-with-progression-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyThu, 30 Apr 2026 14:55:00 +1200https://doi.org/10.2147/BCTT.S577378Multi-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancerhttps://www.dovepress.com/multi-omics-characterization-of-abhd12-across-pan-cancer-and-validatio-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 29 Apr 2026 16:45:00 +1200https://doi.org/10.2147/BCTT.S554836Clinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer Cell Lines, Tumor Tissues, and Circulating Tumor DNAhttps://www.dovepress.com/clinical-relevance-of-usp44-expression-and-dna-methylation-status-in-b-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyTue, 28 Apr 2026 03:05:00 +1200https://doi.org/10.2147/BCTT.S599533Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancerhttps://www.dovepress.com/novel-insights-into-the-oncogenic-role-and-clinical-significance-of-or-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyMon, 20 Apr 2026 20:05:00 +1200https://doi.org/10.2147/BCTT.S586715From Axillary Lymph Node Dissection to Sentinel Node Biopsy in Breast Cancer: A 23-Year Population-Based Large-Sample Study with Long-Term Survival Outcomeshttps://www.dovepress.com/from-axillary-lymph-node-dissection-to-sentinel-node-biopsy-in-breast--peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyFri, 17 Apr 2026 23:45:00 +1200https://doi.org/10.2147/BCTT.S573154LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5phttps://www.dovepress.com/linc01128-affects-triple-negative-breast-cancer-progression-through-ta-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyThu, 16 Apr 2026 02:45:00 +1200https://doi.org/10.2147/BCTT.S596228Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Studyhttps://www.dovepress.com/capecitabine-versus-paclitaxel-after-cdk46-inhibitor-progression-in-ho-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 15 Apr 2026 18:10:00 +1200https://doi.org/10.2147/BCTT.S598598HER2 Overexpression in Invasive Breast Carcinoma in the Democratic Republic of Congo and its Association with Selected Clinicopathological Characteristicshttps://www.dovepress.com/her2-overexpression-in-invasive-breast-carcinoma-in-the-democratic-rep-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 15 Apr 2026 12:55:00 +1200https://doi.org/10.2147/BCTT.S600288Single-Cell Profiling Reveals a Treg-Rich, NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor Expressionhttps://www.dovepress.com/single-cell-profiling-reveals-a-treg-rich-nk-cell-depleted-immune-micr-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyTue, 14 Apr 2026 00:25:00 +1200https://doi.org/10.2147/BCTT.S569936Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillancehttps://www.dovepress.com/adjuvant-weekly-paclitaxel-and-trastuzumab-for-her2-positive-early-sta-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyMon, 13 Apr 2026 16:55:00 +1200https://doi.org/10.2147/BCTT.S596107Analysis of Factors Related to Lymph Node Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Correlation Between Plasma Exosomal Circular RNA and Metastasishttps://www.dovepress.com/analysis-of-factors-related-to-lymph-node-metastasis-following-neoadju-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyThu, 09 Apr 2026 16:00:00 +1200https://doi.org/10.2147/BCTT.S588196Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast Cancerhttps://www.dovepress.com/bridging-clinical-trials-to-real-world-clinical-practice-tchp-neoadjuv-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyThu, 09 Apr 2026 04:45:00 +1200https://doi.org/10.2147/BCTT.S559555Peripheral Blood IL-6 and STAT3 Gene Expression as Biomarkers Associated with Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer: A Prospective Cross-Sectional Studyhttps://www.dovepress.com/peripheral-blood-il-6-and-stat3-gene-expression-as-biomarkers-associat-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 08 Apr 2026 18:05:00 +1200https://doi.org/10.2147/BCTT.S593138IFI44 Orchestrates an IL-10–Driven M2 Macrophage Program in Breast Cancer: An Immune Prognostic Signaturehttps://www.dovepress.com/ifi44-orchestrates-an-il-10driven-m2-macrophage-program-in-breast-canc-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 08 Apr 2026 04:15:00 +1200https://doi.org/10.2147/BCTT.S579301Supportive Intervention for Unmet Needs Among Breast Cancer Patients and Their Spousal Caregivers: A Randomized Controlled Trialhttps://www.dovepress.com/supportive-intervention-for-unmet-needs-among-breast-cancer-patients-a-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 08 Apr 2026 03:20:00 +1200https://doi.org/10.2147/BCTT.S585827Discrimination of Triple-Negative Breast Cancer: A Robust Clinical Baseline versus Multimodal Magnetic Resonance Imaging Integrated Models with Assessment of Generalizabilityhttps://www.dovepress.com/discrimination-of-triple-negative-breast-cancer-a-robust-clinical-base-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyThu, 02 Apr 2026 21:05:00 +1300https://doi.org/10.2147/BCTT.S594356Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Reviewhttps://www.dovepress.com/lipid-metabolism-and-breast-cancer-therapy-an-integrative-literature-r-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 01 Apr 2026 18:00:00 +1300https://doi.org/10.2147/BCTT.S575419Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancerhttps://www.dovepress.com/prognostic-value-of-ki-67-and-progesterone-receptor-for-risk-stratific-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 01 Apr 2026 01:05:00 +1300https://doi.org/10.2147/BCTT.S597707Health Related Quality of Life Among Women with Breast Cancer in Mogadishu, Somaliahttps://www.dovepress.com/health-related-quality-of-life-among-women-with-breast-cancer-in-mogad-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyFri, 27 Mar 2026 19:10:00 +1300https://doi.org/10.2147/BCTT.S587275A Retrospective Analysis of a Serum Multi-Biomarker (CA153, TSGF, and CYFRA 21-1) Logistic Regression Model for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancerhttps://www.dovepress.com/a-retrospective-analysis-of-a-serum-multi-biomarker-ca153-tsgf-and-cyf-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyWed, 25 Mar 2026 05:55:00 +1300https://doi.org/10.2147/BCTT.S567301Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Studyhttps://www.dovepress.com/prognostic-significance-of-the-crp-albumin-lymphocyte-index-cally-in-t-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyFri, 13 Mar 2026 21:00:00 +1300https://doi.org/10.2147/BCTT.S582022Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signalinghttps://www.dovepress.com/inhibition-of-mccc2-impedes-tnbc-progression-by-downregulating-leucine-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyTue, 10 Mar 2026 22:45:00 +1300https://doi.org/10.2147/BCTT.S579112Ovarian Escape in Hormone Receptor-Positive Breast Cancer: Mechanisms, Risk Factors, Clinical Consequences, and Management Strategieshttps://www.dovepress.com/ovarian-escape-in-hormone-receptor-positive-breast-cancer-mechanisms-r-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyTue, 10 Mar 2026 15:05:00 +1300https://doi.org/10.2147/BCTT.S586408Development of a Prognostic Stratification Model and Identification of BDH1 as an Oncoprotein in Breast Cancer Based on Subcluster-Specific Markers of B-Cell Subsetshttps://www.dovepress.com/development-of-a-prognostic-stratification-model-and-identification-of-peer-reviewed-fulltext-article-BCTTBreast Cancer: Targets and TherapyTue, 10 Mar 2026 05:45:00 +1300https://doi.org/10.2147/BCTT.S580906